ACM
PTHS

AIGH Capital Management’s Pelthos Therapeutics PTHS Stock Holding History

AIGH Capital Management’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3M Buy
+329,098
New +$8.45M 0.59% 24

Other funds holding PTHS

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CF
Cantor Fitzgerald New York $9.23B AUM 74.53% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AIGH Capital Management's PTHS Position: Q2 2026 in Review

AIGH Capital Management opened a new position in Pelthos Therapeutics (PTHS) in Q2 2026: 329,098 shares worth $9.3M. The stake represents 0.59% of the portfolio and ranks #24 among its holdings.

24 funds tracked by Wall St. Rank hold PTHS as of Q2 2026.

  • AIGH Capital Management held 329,098 shares of Pelthos Therapeutics worth $9.3M as of Q2 2026.
  • Pelthos Therapeutics was a new AIGH Capital Management position in Q2 2026.
  • Pelthos Therapeutics made up 0.59% of AIGH Capital Management's portfolio in Q2 2026, its #24 holding.
  • 24 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.